Soleus Capital Management, L.P. Provention Bio, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$10.12 - $19.45 $1.07 Million - $2.06 Million	-105,941 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $394,693 - $634,054	-33,477 Reduced 24.01%	105,941 $1.8 Million
Q3 2020 Nov 13, 2020	BUY	$10.34 - $15.2 $822,216 - $1.21 Million	79,518 Added 132.75%	139,418 $1.79 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $467,819 - $1.02 Million	59,900 New	59,900 $845,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.